SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-22-000076
Filing Date
2022-09-13
Accepted
2022-09-13 18:40:52
Documents
2
Period of Report
2022-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166310829327646.html 4  
1 FORM 4 wf-form4_166310829327646.xml 4 3593
2 POWER OF ATTORNEY a2022cidara-section16poapa.htm EX-24 3475
  Complete submission text file 0001610618-22-000076.txt   8550
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6310 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address
Daruwala Paul (Reporting) CIK: 0001639144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 221241736